U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06859801) titled 'A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated with Percutaneous Ablation and Palliative Radiation Therapy' on Feb. 28.
Brief Summary: The objective of this study is to evaluate real-world outcomes (e.g., pain, patient reported outcomes, skeletal related events, healthcare utilization, etc.) in patients treated with both percutaneous ablation and palliative radiation therapy (RT).
Study Start Date: July 01, 2025
Study Type: OBSERVATIONAL
Condition:
Bone Cancer Metastatic
Intervention:
DEVICE: Percutaneous Ablation
Percutaneous ablation is a minimally invasive alternative therapy for metas...